Vendeur : Swan Trading Company, GEORGETOWN, TX, Etats-Unis
EUR 55,36
Quantité disponible : 1 disponible(s)
Ajouter au panierhardcover. Etat : Very Good. Hardcover shows only light cover wear. Text is unmarked and binding tight. Ships FAST!
Vendeur : Majestic Books, Hounslow, Royaume-Uni
EUR 115,36
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Revaluation Books, Exeter, Royaume-Uni
EUR 114,58
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Brand New. 2nd edition. 544 pages. 9.50x7.75x1.25 inches. In Stock.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 132,17
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 133,88
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : New.
Langue: anglais
Edité par Elsevier Science Publishing Co Inc, 2018
ISBN 10 : 0128126264 ISBN 13 : 9780128126264
Vendeur : THE SAINT BOOKSTORE, Southport, Royaume-Uni
EUR 125,41
Quantité disponible : Plus de 20 disponibles
Ajouter au panierHardback. Etat : New. New copy - Usually dispatched within 4 working days.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 100,13
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Langue: anglais
Edité par Elsevier Science Dez 2018, 2018
ISBN 10 : 0128126264 ISBN 13 : 9780128126264
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 150
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation. 442 pp. Englisch.
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 158
Quantité disponible : 2 disponible(s)
Ajouter au panierBuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation.